November 12, 2024
The Plant-Based Biologics Market is driven by growing demand for sustainable alternatives
The Plant-Based Biologics Market involves the production of biologics or biopharmaceuticals using plant systems and plant cell culture techniques as an alternative to bacterial and mammalian cell-based productions. Plant-based biologics production platforms can manufacture complex therapeutic proteins including monoclonal antibodies, peptides, and vaccines at commercial scale with human-compatible post-translational modifications similar to mammalian cell systems…